Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

IMPACT OF CARDIAC AUTONOMIC NEUROPATHY ON QT AND QTC INTERVAL IN PATIENTS SCHEDULED FOR CORONARY ARTERY BYPASS GRAFTING

NCT07684768 is registered in ClinicalTrials.gov with Haseki Training and Research Hospital as lead sponsor.

NCT NCT07684768
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07684768 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
IMPACT OF CARDIAC AUTONOMIC NEUROPATHY ON QT AND QTC INTERVAL IN PATIENTS SCHEDULED FOR CORONARY ARTERY BYPASS GRAFTING
Lead sponsor
Haseki Training and Research Hospital
Phase
Observational
Overall status
Completed
Start date
October 5, 2023
Completion date
December 20, 2024
Enrollment
60 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac autonomic neuropathy, coronary artery disease, qt interval prolongation